Citizens Maintains Market Outperform on LeonaBio, Lowers Price Target to $16

Benzinga · 2d ago
Citizens analyst Jason N. Butler maintains LeonaBio (NASDAQ:LONA) with a Market Outperform and lowers the price target from $17 to $16.